name: Level 6 molecular pathology procedure - Neurofilament, light polypeptide (NEFL) full gene sequence analysis


name: Level 6 molecular pathology procedure - Neuroligin 3 (NLGN3) full gene sequence analysis


name: Level 6 molecular pathology procedure - Neuroligin 4, X-linked (NLGN4X) full gene sequence analysis


name: Level 6 molecular pathology procedure - Nuclear receptor binding SET domain protein 1 (NSD1) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Nuclear receptor binding SET domain protein 1 (NSD1) duplication analysis


name: Level 6 molecular pathology procedure - Ornithine carbamoyltransferase (OTC) full gene sequence analysis


name: Level 6 molecular pathology procedure - POU class 1 homeobox 1 (POU1F1) full gene sequence analysis


name: Level 6 molecular pathology procedure - PTEN induced putative kinase 1 (PINK1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Parkinson protein 2, E3 ubiquitin protein ligase (parkin) (PARK2) deletion analysis


name: Level 6 molecular pathology procedure - Parkinson protein 2, E3 ubiquitin protein ligase (parkin) (PARK2) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Parkinson protein 2, E3 ubiquitin protein ligase (parkin) (PARK2) duplication analysis


name: Level 6 molecular pathology procedure - Periaxin (PRX) full gene sequence analysis


name: Level 6 molecular pathology procedure - Platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (PAFAH1B1) deletion analysis


name: Level 6 molecular pathology procedure - Platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (PAFAH1B1) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (PAFAH1B1) duplication analysis


name: Level 6 molecular pathology procedure - Polyglutamine binding protein 1 (PQBP1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Presenilin 1 (PSEN1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Propionyl CoA carboxylase, alpha polypeptide (PCCA) deletion analysis


name: Level 6 molecular pathology procedure - Propionyl CoA carboxylase, alpha polypeptide (PCCA) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Propionyl CoA carboxylase, alpha polypeptide (PCCA) duplication analysis


name: Level 6 molecular pathology procedure - Proteolipid protein 1 (PLP1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Protocadherin 19 (PCDH19) full gene sequence analysis


name: Level 6 molecular pathology procedure - Pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1) deletion analysis


name: Level 6 molecular pathology procedure - Pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1) duplication analysis


name: Level 6 molecular pathology procedure - Pyruvate dehydrogenase [lipoamide] beta (PDHB) full gene sequence analysis


name: Level 6 molecular pathology procedure - Pyruvate kinase, liver and RBC (PKLR) full gene sequence analysis


name: Level 6 molecular pathology procedure - RAB7A, member RAS oncogene family (RAB7A) full gene sequence analysis


name: Level 6 molecular pathology procedure - Receptor accessory protein 1 (REEP1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis of exon 10


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis of exon 11


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis of exon 13


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis of exon 14


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis of exon 15


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis of exon 16


name: Level 6 molecular pathology procedure - Ret proto-oncogene (RET) targeted sequence analysis of exons 10, 11, and 13-16


name: Level 6 molecular pathology procedure - Retinoic acid induced 1 (RAI1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Ribonucleotide reductase M2 B (TP53 inducible) (RRM2B) full gene sequence analysis


name: Level 6 molecular pathology procedure - Ribosomal protein S19 (RPS19) full gene sequence analysis


name: Level 6 molecular pathology procedure - SCO cytochrome oxidase deficient homolog 1 (SCO1) full gene sequence analysis


name: Level 6 molecular pathology procedure - SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae) (SIL1) full gene sequence analysis


name: Level 6 molecular pathology procedure - SMAD family member 4 (SMAD4) deletion analysis


name: Level 6 molecular pathology procedure - SMAD family member 4 (SMAD4) deletion and duplication analysis


name: Level 6 molecular pathology procedure - SMAD family member 4 (SMAD4) duplication analysis


name: Level 6 molecular pathology procedure - Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) (SGCA) full gene sequence analysis


name: Level 6 molecular pathology procedure - Sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) (SGCB) full gene sequence analysis


name: Level 6 molecular pathology procedure - Sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) (SGCD) full gene sequence analysis


name: Level 6 molecular pathology procedure - Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG) full gene sequence analysis


name: Level 6 molecular pathology procedure - Serine/threonine kinase 11 (STK11) full gene sequence analysis


name: Level 6 molecular pathology procedure - Short stature homeobox (SHOX) full gene sequence analysis


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exon 12


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exon 13


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exon 14


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exon 16


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exon 17


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exon 20


name: Level 6 molecular pathology procedure - Signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) targeted sequence analysis of exon 21


name: Level 6 molecular pathology procedure - Soc-2 suppressor of clear homolog (SHOC2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Solute carrier family 16, member 2 (thyroid hormone transporter) (SLC16A2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Solute carrier family 22 (organic cation/carnitine transporter), member 5 (SLC22A5) full gene sequence analysis


name: Level 6 molecular pathology procedure - Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (SLC25A20) full gene sequence analysis


name: Level 6 molecular pathology procedure - Spastic paraplegia 7 (pure and complicated autosomal recessive) (SPG7) deletion analysis


name: Level 6 molecular pathology procedure - Spastic paraplegia 7 (pure and complicated autosomal recessive) (SPG7) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Spastic paraplegia 7 (pure and complicated autosomal recessive) (SPG7) duplication analysis


name: Level 6 molecular pathology procedure - Spastin (SPAST) deletion analysis


name: Level 6 molecular pathology procedure - Spastin (SPAST) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Spastin (SPAST) duplication analysis


name: Level 6 molecular pathology procedure - Sprouty-related, EVH1 domain containing 1 (SPRED1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Succinate dehydrogenase complex, subunit B, iron sulfur (SDHB) full gene sequence analysis


name: Level 6 molecular pathology procedure - Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa (SDHC) full gene sequence analysis


name: Level 6 molecular pathology procedure - Surfeit 1 (SURF1) full gene sequence analysis


name: Level 6 molecular pathology procedure - T-box 5 (TBX5) full gene sequence analysis


name: Level 6 molecular pathology procedure - TAR DNA binding protein (TARDBP) full gene sequence analysis


name: Level 6 molecular pathology procedure - Thymidine kinase 2, mitochondrial (TK2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Thymidine phosphorylase (TYMP) full gene sequence analysis


name: Level 6 molecular pathology procedure - Thyroid hormone receptor, beta (THRB) full gene sequence analysis


name: Level 6 molecular pathology procedure - Transcription factor 4 (TCF4) deletion analysis


name: Level 6 molecular pathology procedure - Transcription factor 4 (TCF4) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Transcription factor 4 (TCF4) duplication analysis


name: Level 6 molecular pathology procedure - Transforming growth factor, beta receptor 1 (TGFBR1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Transforming growth factor, beta receptor 2 (TGFBR2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Tropomyosin 1 (alpha) (TPM1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Troponin C type 1 (slow) (TNNC1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Troponin I, type 3 (cardiac) (TNNI3) full gene sequence


name: Level 6 molecular pathology procedure - von Willebrand factor (VWF) targeted sequence analysis of exons 18-20


name: Level 6 molecular pathology procedure - von Willebrand factor (VWF) targeted sequence analysis of exons 18-20 and 23-25


name: Level 6 molecular pathology procedure - von Willebrand factor (VWF) targeted sequence analysis of exons 23-25


name: Level 6 molecular pathology procedure - Wilms tumor 1 (WT1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Zinc finger E-box binding homeobox 2 (ZEB2) full gene sequence analysis


name: Level 7 molecular pathology procedure - ATPase, Cu++ transporting, beta polypeptide (ATP7B) full gene sequence analysis


name: Level 7 molecular pathology procedure - ATPase, Na+/K+ transporting, alpha 2 polypeptide (ATP1A2) full gene sequence


name: Level 7 molecular pathology procedure - Actinin, alpha 4 (ACTN4) full gene sequence analysis


name: Level 7 molecular pathology procedure - Acyl-CoA dehydrogenase, very long chain (ACADVL) full gene sequence analysis


name: Level 7 molecular pathology procedure - Aldehyde dehydrogenase 7 family, member A1 (ALDH7A1) full gene sequence


name: Level 7 molecular pathology procedure - Amyloid beta [A4] precursor protein (APP) full gene sequence analysis


name: Level 7 molecular pathology procedure - Anoctamin 5 (ANO5) full gene sequence analysis


name: Level 7 molecular pathology procedure - Cadherin 1, type 1, E-cadherin [epithelial] (CDH1) full gene sequence analysis


name: Level 7 molecular pathology procedure - Calpain 3 (CAPN3) full gene sequence analysis


name: Level 7 molecular pathology procedure - Cyclin-dependent kinase-like 5 (CDKL5) full gene sequence analysis


name: Level 7 molecular pathology procedure - Cystathionine-beta-synthase (CBS) full gene sequence analysis


name: Level 7 molecular pathology procedure - Dihydrolipoamide S-acetyltransferase (DLAT) full gene sequence analysis


name: Level 7 molecular pathology procedure - Dihydrolipoamide dehydrogenase (DLD) full gene sequence analysis


name: Level 7 molecular pathology procedure - Eyes absent homolog 1 [Drosophila] (EYA1) full gene sequence analysis


name: Level 7 molecular pathology procedure - Galactose-1-phosphate uridylyltransferase (GALT) full gene sequence analysis


name: Level 7 molecular pathology procedure - Glucokinase [hexokinase 4] (GCK) full gene sequence analysis


name: Level 7 molecular pathology procedure - Glucosidase, alpha; acid (GAA) full gene sequence analysis


name: Level 7 molecular pathology procedure - Glutaryl-CoA dehydrogenase (GCDH) full gene sequence analysis


name: Level 7 molecular pathology procedure - Hepatocyte nuclear factor 4, alpha (HNF4A) full gene sequence analysis


name: Level 7 molecular pathology procedure - Hexosaminidase A, alpha polypeptide (HEXA) full gene sequence analysis


name: Level 7 molecular pathology procedure - Hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase [trifunctional protein] alpha subunit (HADHA) full gene sequence analysis


name: Level 7 molecular pathology procedure - Isovaleryl-CoA dehydrogenase (IVD) full gene sequence analysis


name: Level 7 molecular pathology procedure - LIM domain binding 3 (LDB3) full gene sequence analysis


name: Level 7 molecular pathology procedure - Lamin A/C (LMNA) full gene sequence analysis


name: Level 7 molecular pathology procedure - Methylcrotonoyl-CoA carboxylase 2 [beta] (MCCC2) full gene sequence analysis


name: Level 7 molecular pathology procedure - Mitogen-activated protein kinase 1 (MAP2K1) full gene sequence analysis


name: Level 7 molecular pathology procedure - MutY homolog [E. coli] (MUTYH) full gene sequence analysis


name: Level 7 molecular pathology procedure - Neurofibromin 2 [merlin](NF2) full gene sequence analysis


name: Level 7 molecular pathology procedure - Notch 3 (NOTCH3) targeted sequence analysis


name: Level 7 molecular pathology procedure - Notch 3 (NOTCH3) targeted sequence analysis of exons 1-23


name: Level 7 molecular pathology procedure - Nuclear receptor binding SET domain protein 1 (NSD1) full gene sequence analysis


name: Level 7 molecular pathology procedure - Paired box 2 (PAX2) full gene sequence analysis


name: Level 7 molecular pathology procedure - Phenylalanine hydroxylase (PAH) full gene sequence analysis


name: Level 7 molecular pathology procedure - Phosphorylase, glycogen, muscle (PYGM) full gene sequence analysis


name: Level 7 molecular pathology procedure - Polymerase [DNA directed], gamma (POLG) full gene sequence analysis


name: Level 7 molecular pathology procedure - Presenilin 2 [Alzheimer disease 4] (PSEN2) full gene sequence analysis


name: Level 7 molecular pathology procedure - Propionyl CoA carboxylase, beta polypeptide (PCCB) full gene sequence analysis


name: Level 7 molecular pathology procedure - Protein O-linked mannose beta1,2-N acetylglucosaminyltransferase (POMGNT1) full gene sequence analysis


name: Level 7 molecular pathology procedure - Protein kinase, AMP-activated, gamma 2 noncatalytic subunit (PRKAG2) full gene sequence analysis


name: Level 7 molecular pathology procedure - Protein tyrosine phosphatase, non-receptor type 11 (PTPN11) full gene sequence analysis


name: Level 7 molecular pathology procedure - Protein-O-mannosyltransferase 1 (POMT1) full gene sequence analysis


name: Level 7 molecular pathology procedure - Protein-O-mannosyltransferase 2 (POMT2) full gene sequence analysis


name: Level 7 molecular pathology procedure - Pyruvate carboxylase (PC) full gene sequence analysis


name: Level 7 molecular pathology procedure - Pyruvate dehydrogenase [lipoamide] alpha 1 (PDHA1) full gene sequence analysis


name: Level 7 molecular pathology procedure - Pyruvate dehydrogenase complex, component X (PDHX) full gene sequence analysis


name: Level 7 molecular pathology procedure - Ret proto-oncogene (RET) full gene sequence analysis


name: Level 7 molecular pathology procedure - Ryanodine receptor 1, skeletal (RYR1) targeted sequence analysis of exons with functionally-confirmed mutations


name: Level 7 molecular pathology procedure - Solute carrier family 26, member 4 (SLC26A4) full gene sequence analysis


name: Level 7 molecular pathology procedure - Solute carrier family 9 [sodium/hydrogen exchanger], member 6 (SLC9A6) full gene sequence analysis


name: Level 7 molecular pathology procedure - Son of sevenless homolog 1 (SOS1) full gene sequence analysis


name: Level 7 molecular pathology procedure - Tafazzin (TAZ) full gene sequence analysis


name: Level 7 molecular pathology procedure - Troponin T, type 2 [cardiac] (TNNT2) full gene sequence analysis


name: Level 7 molecular pathology procedure - Tuberous sclerosis 1 (TSC1) full gene sequence analysis


name: Level 7 molecular pathology procedure -Ubiquitin protein ligase E3A (UBE3A) full gene sequence analysis


name: Level 7 molecular pathology procedure - V-raf-1 murine leukemia viral oncogene homolog 1 (RAF1) full gene sequence analysis


name: Level 7 molecular pathology procedure - von Willebrand factor (VWF) extended targeted sequence analysis


name: Level 7 molecular pathology procedure - von Willebrand factor (VWF) extended targeted sequence analysis of exons 11-16, 24-26, 51, and 52


name: Level 7 molecular pathology procedure -von Willebrand factor (VWF) targeted sequence analysis of exon 51


name: Level 7 molecular pathology procedure -von Willebrand factor (VWF) targeted sequence analysis of exon 52


name: Level 7 molecular pathology procedure - Von Willebrand factor (VWF) targeted sequence analysis of exons 11-16


name: Level 7 molecular pathology procedure - von Willebrand factor (VWF) targeted sequence analysis of exons 24-26


name: Level 8 molecular pathology procedure - ATP-binding cassette, sub-family C (CFTR/MRP), member 8 (ABCC8) full gene sequence analysis


name: Level 8 molecular pathology procedure - Apolipoprotein B (APOB) full gene sequence analysis


name: Level 8 molecular pathology procedure - Chromodomain helicase DNA binding protein 7 (CHD7) full gene sequence analysis


name: Level 8 molecular pathology procedure - Coagulation factor VIII (F8) full gene sequence analysis


name: Level 8 molecular pathology procedure - Jagged 1 (JAG1) full gene sequence analysis


name: Level 8 molecular pathology procedure - Myosin VIIA (MYO7A) full gene sequence analysis


name: Level 8 molecular pathology procedure - Myosin binding protein C, cardiac (MYBPC3) full gene sequence analysis


name: Level 8 molecular pathology procedure - Myosin, heavy chain 6, cardiac muscle, alpha (MYH6) full gene sequence analysis


name: Level 8 molecular pathology procedure - Myosin, heavy chain 7, cardiac muscle, beta (MYH7) full gene sequence analysis


name: Level 8 molecular pathology procedure - Notch 1 (NOTCH1) full gene sequence analysis


name: Level 8 molecular pathology procedure - Optic atrophy 1 (OPA1) full gene sequence analysis


name: Level 8 molecular pathology procedure - Protocadherin-related 15 (PCDH15) full gene sequence analysis


name: Level 8 molecular pathology procedure - Sodium channel, voltage-gated, type 1, alpha subunit (SCN1A) full gene sequence analysis


name: Level 8 molecular pathology procedure - Sodium channel, voltage-gated, type V, alpha subunit (SCN5A) full gene sequence analysis


name: Level 8 molecular pathology procedure - Tuberous sclerosis 2 (TSC2) full gene sequence analysis


name: Level 8 molecular pathology procedure - Usher syndrome 1C (autosomal recessive, severe) (USH1C) full gene sequence analysis


name: Level 9 molecular pathology procedure - Ataxia telangiectasia mutated (ATM) full gene sequence analysis


name: Level 9 molecular pathology procedure - Cadherin-related 23 (CDH23) full gene sequence analysis


name: Level 9 molecular pathology procedure - Centrosomal protein 290kDa (CEP290) full gene sequence


name: Level 9 molecular pathology procedure - Collagen, type I, alpha 1 (COL1A1) full gene sequence analysis


name: Level 9 molecular pathology procedure - Dysferlin, limb girdle muscular dystrophy 2B [autosomal recessive] (DYSF) full gene sequence analysis


name: Level 9 molecular pathology procedure - Fibrillin 1 (FBN1) full gene sequence analysis


name: Level 9 molecular pathology procedure - Neurofibromin 1 (NF1) full gene sequence analysis


name: Level 9 molecular pathology procedure - Ryanodine receptor 1, skeletal (RYR1) full gene sequence analysis


name: Level 9 molecular pathology procedure - Usher syndrome 2A [autosomal recessive, mild] (USH2A) full gene sequence analysis


name: Level 9 molecular pathology procedure - von Willebrand factor (VWF) full gene sequence analysis


name: Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes


name: Aortic dilation gene sequence analysis panel for detection of FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK variants


name: Aortic dysfunction gene sequence analysis panel for detection of FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK variants


name: Test for detecting genes associated with heart disease, duplication/deletion analysis panel


name: Aortic dilation gene deletion and duplication analysis panel - TGFBR1, TGFBR2, MYH11, and COL3A1 variants


name: Aortic dysfunction gene deletion and duplication analysis panel - TGFBR1, TGFBR2, MYH11, and COL3A1 variants


name: Test for detecting genes for disorders related to Ashkenazi Jews, genomic sequence analysis panel, at least 9 genes


name: Ashkenazi Jewish associated disorders genomic sequence analysis panel with sequencing of 9 or more genes, including ASPA, BLM, CFTR, FANCC, GBA, HEXA, IKBKAP, MCOLN1, and SMPD1


name: Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 10 genes


name: Cardiac ion channelopathies genomic sequence analysis panel with sequencing of 10 or more genes, including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A


name: Test for detecting genes associated with heart disease, duplication/deletion analysis panel, at least 2 genes


name: Cardiac ion channelopathies deletion and duplication analysis panel with analysis of multiple genes, including KCNH2 and KCNQ1


name: Test for detecting exome, sequence analysis, each comparator exome


name: Exome sequence analysis re-evaluation of previously obtained exome sequence


name: Epilepsy genomic sequence analysis panel, must include analyses for ALDH7A1, CACNA1A, CDKL5, CHD2, GABRG2, GRIN2A, KCNQ2, MECP2, PCDH19, POLG, PRRT2, SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC9A6, STXBP1, SYNGAP1, TCF4, TPP1, TSC1, TSC2, and ZEB2


name: Gene analysis panel for evaluation of genes associated with epilepsy


name: Epilepsy genomic sequence analysis panel, including ALDH7A1, CACNA1A, CDKL5, CHD2, GABRG2, GRIN2A, KCNQ2, MECP2, PCDH19, POLG, PRRT2, SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC9A6, STXBP1, SYNGAP1, TCF4, TPP1, TSC1, TSC2, and ZEB2


name: Fetal chromosomal aneuploid genomic sequence analysis panel with analysis of chromosomes 13, 18, and 21


name: Test for detecting genes associated with fetal disease, microdeletion(s) genomic sequence analysis


name: Test for detecting genes associated with disease, genome sequence analysis


name: Test for detecting genes associated with disease, genome sequence analysis, each additional comparator genome


name: Genome sequence analysis for each comparator exome


name: Reevaluation test of previously obtained genome sequence


name: Re-evaluation of previously obtained genome sequence


name: Test for detecting genes causing hearing loss genomic sequence analysis panel, at least 60 genes


name: Hearing loss genomic sequence analysis panel with sequencing of 60 or more genes, including CDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3, USH1C, USH1G, USH2A, and WFS1 genes


name: Hearing loss gene analysis panel for deletion and duplication variants, including STRC and DFNB1 deletions in GJB2 and GJB6 genes


name: Hereditary breast cancer-related disorders genomic sequence analysis panel with 10 or more genes, including BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2, PTEN, STK11, and TP53


name: Hereditary breast cancer-related disorders for deletion and duplication analysis panel, including BRCA1, BRCA2, MLH1, MSH2, and STK11


name: Hereditary retinal disorders genomic sequence analysis panel with sequencing of 15 or more genes, including ABCA4, CNGA1, CRB1, EYS, PDE6A, PDE6B, PRPF31, PRPH2, RDH12, RHO, RP1, RP2, RPE65, RPGR, and USH2A


name: Hereditary colon cancer disorders genomic sequence analysis panel with sequencing of 10 or more genes, including APC, BMPR1A, CDH1, MLH1, MSH2, MSH6, MUTYH, PTEN, SMAD4, and STK11 genes


name: Test for detecting genes associated with colon cancer, duplication/deletion analysis panel, at least 5 genes


name: Hereditary colon cancer disorders deletion and duplication analysis panel with analysis of 5 or more genes, including MLH1, MSH2, EPCAM, SMAD4, and STK11 genes


name: Hereditary neuroendocrine tumor disorders genomic sequence analysis panel with sequencing of 6 or more genes, including MAX, SDHB, SDHC, SDHD, TMEM127, and VHL


name: Hereditary neuroendocrine tumor disorders deletion and duplication analysis panel, including SDHB, SDHC, SDHD, and VHL gene analysis


name: Hereditary cardiomyopathy genomic sequence analysis panel with sequencing of 5 or more genes, including DSG2, MYBPC3, MYH7, PKP2, and TTN


name: Nuclear encoded mitochondrial genomic sequence panel including the analysis of 100 or more genes, including BCS1L, C10orf2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2, and TYMP


name: Noonan spectrum disorders genomic sequence analysis panel with sequencing of 12 or more genes, including BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, and SOS1


name: Severe inherited conditions genomic sequence analysis panel with sequencing of 15 or more genes, including ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, and PAH


name: Hereditary peripheral neuropathies genomic sequence analysis panel with sequencing of 5 or more genes, including BSCL2, GJB1, MFN2, MPZ, REEP1, SPAST, SPG11, and SPTLC1


name: Test for detecting genes associated with disease, genomic sequence, must include sequence analysis of entire mitochondrial genome


name: Whole mitochondrial genome genomic sequence analysis with detection of heteroplasmy


name: Test for detecting genes associated with disease, whole mitochondrial genome


name: Whole mitochondrial genome large deletion analysis panel


name: Whole mitochondrial genome large deletion analysis panel with heteroplasmy detection


name: X-linked intellectual disability (XLID) genomic sequence analysis panel with sequencing of 60 or more genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2 genes


name: Test for detecting genes associated with intellectual disability, duplication/deletion gene analysis, at least 60 genes


name: X-linked intellectual disability (XLID) deletion and duplication analysis panel with analysis of 60 or more genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2


name: Serum analysis of 12 biomarkers for rheumatoid arthritis using immunoassay and prognostic algorithm reported as a disease activity score


name: Coronary artery disease mRNA gene expression profiling by real time reverse transcription polymerase chain reaction (RT-PCR) of 23 genes, algorithm reported as a risk score


name: Biochemical assay of CA-125 and HE4 proteins utilizing serum and menopausal status for ovarian cancer risk score


name: Genetic profiling on oncology biopsy of ovarian lesions, assays of five proteins


name: Biochemical assay of CA-125, apolipoprotein A1, beta-2 microglobulin, transferrin, and prealbumin proteins utilizing serum, algorithm reported as an ovarian cancer risk score


name: Oncology microarray gene expression profiling of more than 2000 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as tissue similarity scores


name: Biochemical assay of glucose, HbA1c, insulin, hs-CRP, adiponectin, ferritin, and interleukin 2-receptor alpha utilizing plasma, algorithm reported a risk score for type 2 diabetes


name: Biochemical assay of glucose, HbA1c, insulin, hs-CRP, adiponectin, ferritin, and interleukin 2-receptor alpha utilizing serum, algorithm reported a risk score for type 2 diabetes


name: DNA sequence analysis of selected regions of chromosomes 21, 18, and 13 for fetal aneuploidy, utilizing maternal plasma, algorithm reported as risk score for each trisomy


name: Biochemical assay of PAPP-A and hCG, utilizing maternal serum for fetal congenital abnormality, algorithm reported as risk score


name: Biochemical assay of PAPP-A, hCG, and DIA, utilizing maternal serum, algorithm reported a risk score for fetal congenital abnormality


name: Biochemical assay of 3 analytes, AFP, uE3, and hCG, utilizing maternal serum and algorithm reported as fetal congenital abnormality risk score


name: Biochemical assay of 4 analytes, AFP, uE3, hCG, and DIA utilizing maternal serum for fetal congenital abnormality, algorithm reported as a risk score


name: Biochemical assay of 5 analytes, AFP, uE3, total hCG, hyperglycosylated hCG, and DIA utilizing maternal serum for fetal congenital abnormality, algorithm reported as a risk score


name: Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result for bacterial vaginosis


name: Measurement of RNA of bacteria in vaginal fluid specimen


name: Quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species in vaginal fluid specimen, algorithm reported as positive or negative for bacterial vaginosis


name: Infectious disease, bacterial vaginosis and vaginitis, quantitative real-time amplification of DNA markers for Gardnerella vaginalis, Atopobium vaginae, Megasphaera type 1, Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), and Lactobacillus species (L. crispatus and L. jensenii), utilizing vaginal-fluid specimens, algorithm reported as a positive or negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis and/or Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata, Candida krusei, when reported


name: Measurement of DNA of bacteria in vaginal fluid specimen


name: Quantitative real-time amplification of DNA markers for Gardnerella vaginalis, Atopobium vaginae, Megasphaera type 1, Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), and Lactobacillus species (L. crispatus and L. jensenii) in vaginal fluid specimen, algorithm reported as positive or negative for high likelihood of bacterial vaginosis, with separate detection of Trichomonas vaginalis and/or Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata, Candida krusei


name: Breast cancer mRNA gene expression profiling by real time reverse transcription polymerase chain reaction (RT-PCR) of 11 genes (7 content and 4 housekeeping), using formalin-fixed paraffin-embedded tissue, algorithms reported as percentage risk for metastatic recurrence and likelihood of benefit from extended endocrine therapy


name: Breast cancer (mRNA) gene expression profiling by real time reverse transcription polymerase chain reaction (RT-PCR) of 21 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence score


name: Gene analysis of breast tumor tissue, profiling by hybrid capture of 58 genes


name: Gene analysis of breast tumor tissue, profiling of 70 content genes and 465 housekeeping genes


name: mRNA gene expression profiling by real-time reverse transcription polymerase chain reaction (RT-PCR) of 12 genes (8 content and 4 housekeeping) in formalin-fixed paraffin-embedded tissue, algorithm reported as breast cancer recurrence risk score


name: Colon cancer (mRNA) gene expression profiling by real time reverse transcription polymerase chain reaction (RT-PCR) of 12 genes (7 content and 5 housekeeping) algorithm reported as a recurrence score


name: Colorectal cancer screening by quantitative real time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin utilizing stool, algorithm reported as a positive or negative result


name: Oncology (cutaneous melanoma), mRNA, gene expression profiling by real-time RT-PCR of 31 genes (28 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence risk, including likelihood of sentinel lymph node metastasis


name: Cutaneous melanoma mRNA gene expression profiling by real-time polymerase chain reaction (RT-PCR) of 31 genes (28 content and 3 housekeeping), in tissue specimen, algorithm reported as recurrence risk, including likelihood of sentinel lymph node metastasis


name: Culture of live tumor cells and chemotherapy drug response by staining, first single drug or drug combination


name: Gynecologic live tumor cell culture and chemotherapeutic response by DAPI stain, first single drug


name: Gynecologic live tumor cell culture and chemotherapeutic response by DAPI stain, each additional drug combination


name: Gynecologic live tumor cell culture and chemotherapeutic response by DAPI stain, each additional single drug


name: Lung cancer survival likelihood profiling using mass spectrometric 8-protein signature including amyloid A, utilizing serum, and algorithm reported as good versus poor overall survival


name: mRNA gene expression analysis by real time reverse transcription polymerase chain reaction (RT-PCR) of 92 genes for tumor classification, algorithm reported as a probability of a predicted main cancer type and subtype


name: Prostate cancer mRNA gene expression profiling by real time reverse transcription polymerase chain reaction (RT-PCR) of 46 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a disease-specific mortality risk score


name: mRNA microarray gene expression profiling of 22 content genes in formalin-fixed paraffin-embedded tissue, algorithm reported as prostate metastasis risk score


name: Oncology (thyroid), mRNA, gene expression analysis of 10,196 genes, utilizing fine needle aspirate, algorithm reported as a categorical result (eg, benign or suspicious)


name: mRNA gene analysis of 10,196 genes in fine needle aspiration thyroid specimen, reported as category result (e.g. benign, suspicious)


name: mRNA gene expression analysis of 10,196 genes in fine needle aspirate thyroid specimen, algorithm reported as category (benign, suspicious, or malignant)


name: Gene analysis of prostate tumor tissue, profiling by real-time PCR of 3 genes


name: Prostate cancer promoter methylation profiling by real time polymerase chain reaction (PCR) of 3 genes (GSTP1, APC, RASSF1), utilizing formalin-fixed paraffin embedded tissue, algorithm reported as a likelihood of prostate cancer detection on repeat biopsy


name: mRNA gene expression profiling by real-time reverse transcription polymerase chain reaction (RT-PCR) of 15 genes (12 content and 3 housekeeping), in fine needle aspirate, algorithm reported as risk of uveal melanoma metastasis


name: mRNA gene expression profiling by real-time reverse transcription polymerase chain reaction (RT-PCR) of 15 genes (12 content and 3 housekeeping), in formalin-fixed paraffin-embedded tissue, algorithm reported as risk of uveal melanoma metastasis


name: Pulmonary disease (idiopathic pulmonary fibrosis [IPF]), mRNA, gene expression analysis of 190 genes, utilizing transbronchial biopsies, diagnostic algorithm reported as categorical result (eg, positive or negative for high probability of usual interstitial pneumonia [UIP])


name: mRNA gene analysis of 190 genes associated with lung disease (idiopathic pulmonary fibrosis) in transbronchial biopsy specimen of lung


name: mRNA, gene expression analysis of 190 genes associated with idiopathic pulmonary fibrosis (IPF) in transbronchial biopsy specimen, diagnostic algorithm reported as positive or negative for high probability of usual interstitial pneumonia


name: Heart transplant mRNA gene expression profiling by real time quantitative polymerase chain reaction (PCR) of 20 genes utilizing subfraction of peripheral blood, algorithm reported as a rejection risk score


name: Measurement of alanine aminotransferase, A2-macroglobulin, apolipoprotein A-1, total bilirubin, gamma-glutamyl transferase (GGT), and haptoglobin in serum for assessment of chronic hepatitis C virus infection, prognostic algorithm reported as scores for fibrosis, and necroinflammatory activity in liver


name: Quantitative measurement of acetoacetic acid in serum


name: Quantitative measurement of beta-hydroxybutyrate in serum


name: Quantitative measurement of ketone body in serum


name: Qualitative analysis of acylcarnitine, each specimen


name: Quantitative measurement of acylcarnitine


name: Quantitative measurement of albumin in amniotic fluid, each specimen


name: Quantitative measurement of albumin in cerebrospinal fluid, each specimen


name: Quantitative measurement of albumin in other source, each specimen


name: Semiquantitative analysis of albumin in urine using reagent strip assay


name: Semiquantitative analysis of microalbumin in urine using reagent strip assay


name: Semiquantitative measurement of albumin in urine


name: Semiquantitative measurement of mircroalbumin in urine


name: Measurement of alcohol level in breath specimen


name: Measurement of ethanol in breath specimen


name: Alcohol (ethanol); any specimen except urine and breath, immunoassay (eg, IA, EIA, ELISA, RIA, EMIT, FPIA) and enzymatic methods (eg, alcohol dehydrogenase)


name: Measurement of alcohol level in specimen other than breath or urine


name: Measurement of ethanol by alcohol dehydrogenase assay for ethanol in specimen other than breath or urine


name: Measurement of ethanol by enzymatic assay for ethanol in specimen other than breath or urine


name: Measurement of ethanol by enzyme immunoassay (EIA) for ethanol in specimen other than breath or urine


name: Measurement of ethanol by enzyme-linked immunosorbent assay (ELISA) for ethanol in specimen other than breath or urine , immunoassay (eg, IA, EIA, ELISA, RIA, EMIT, FPIA) and enzymatic methods (eg, alcohol dehydrogenase)


name: Measurement of ethanol by fluorescence polarization immunoassay (FPIA) for ethanol in specimen other than breath or urine


name: Measurement of ethanol by radio immunoassay (RIA) for ethanol in specimen other than breath or urine


name: Alpha-1-antitrypsin (protein) blood test, total


name: Qualitative analysis of single amino acid


name: Amino acid analysis, multiple amino acids, qualitative, each specimen


name: Amino acid analysis, quantitative, each specimen


name: Quantitative testing of single amino acid


name: Amino acid level, 2 to 5 amino acids, quantitative, each specimen


name: Measurement of 2-5 amino acids, each specimen


name: Measurement of 6 or more amino acids, each specimen


name: Measurement of apolipoprotein, each apolipoprotein tested


name: Measurement of biotinidase, each specimen


name: Qualitative analysis of occult blood in consecutively collected fecal specimens by peroxidase activity, single determination, for colorectal neoplasm screening


name: Qualitative analysis of nonfecal occult blood by peroxidase activity


name: Stool analysis for blood, by peroxidase activity


name: Qualitative analysis of occult blood in feces by peroxidase activity, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening


name: Qualitative fecal hemoglobin, 1-3 simultaneous determinations by immunoassay for blood in feces


name: Calcium level, after calcium infusion test


name: Measurement of carbon dioxide (bicarbonate)


name: Measurement of carcinoembryonic antigen (CEA)


name: Quantitative measurement of free and total carnitine


name: Measurement of cholinesterase in red blood cells (RBCs)


name: Quantitative measurement of chondroitin B sulfate


name: Qualitative column chromatography for nondrug analyte, each specimen


name: Qualitative column chromatography with mass spectroscopy for nondrug analyte, each specimen


name: Quantitative column chromatography for nondrug analyte, each specimen


name: Quantitative column chromatography with mass spectroscopy for nondrug analyte, each specimen


name: Creatine kinase (cardiac enzyme) level, total


name: Measurement of total creatine kinase (CK/CPK)


name: Creatine kinase (cardiac enzyme) level, isoenzymes


name: Creatine kinase (cardiac enzyme) level, MB fraction only


name: Measurement of creatine kinase (CK/CPK) muscle and brain (MB) fraction


name: Measurement of creatine kinase (CK/CPK) isoforms


name: Measurement of creatinine (source other than blood)


name: Semiquantitative analysis of cryoglobulin


name: Cyanocobalamin (vitamin B-12) level, unsaturated binding capacity


name: Measurement of dihydrotestosterone (DHT)


name: Semiquantitative analysis of pancreatic elastase (EL-1) in feces


name: Enzyme activity measurement, nonradioactive substrate


name: Assay of enzyme activity in blood cells (not elsewhere specified) with nonradioactive substrate, each specimen


name: Assay of enzyme activity in cultured cells (not elsewhere specified) with nonradioactive substrate, each specimen


name: Assay of enzyme activity in tissue (not elsewhere specified) with nonradioactive substrate, each specimen


name: Assay of enzyme activity in blood cells (not elsewhere specified) with radioactive substrate, each specimen


name: Assay of enzyme activity in cultured cells (not elsewhere specified) with radioactive substrate, each specimen


name: Assay of enzyme activity in tissue (not elsewhere specified) with radioactive substrate, each specimen


name: Electrophoretic technique (not elsewhere specified)


name: Measurement of total estradiol (hormone)


name: Estradiol; free, direct measurement (eg, equilibrium dialysis)


name: Stool fat or lipids analysis, qualitative


name: Quantitative measurement of fat in feces


name: Quantitative measurement of lipids in feces


name: Stool fat differential measurement, quantitative


name: Quantitative measurement of fat differential in feces


name: Measurement of folic acid in red blood cells (RBCs)


name: Measurement of galactokinase in red blood cells (RBCs)


name: Gammaglobulin (immune system protein) measurement, immunoglobulin subclasses


name: Analysis of bicarbonate (HCO3) of blood in combination with other blood gas


name: Analysis of carbon dioxide (CO2) of blood in combination with other blood gas


name: Analysis of pH of blood in combination with other blood gas


name: Analysis of partial pressure of carbon dioxide (pCO2) of blood in combination with other blood gas


name: Analysis of partial pressure of oxygen (pO2) of blood in combination with other blood gas


name: Calculated oxygen (O2) saturation of blood


name: Blood gases measurement, with O2 saturation


name: Analysis of HCO3 of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of carbon dioxide (CO2) of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of pCO2 of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of pH of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of pO2 of blood in combination with other blood gas with oxygen (O2) saturation


name: Direct measurement of only oxygen (O2) saturation in blood (except pulse oximetry)


name: Gastric acid analysis with pH, each specimen


name: Gastrin (GI tract hormone) level, after secretin stimulation


name: Measurement of glucose in blood (except reagent strip)


name: Blood glucose (sugar) tolerance test, 3 specimens


name: Glucose tolerance test (GTT), 3 specimens


name: Blood glucose (sugar) tolerance test, each additional beyond 3 specimens


name: Glucose tolerance test (GTT), each additional specimen beyond 3


name: Quantitative measurement of glucose-6-phosphate dehydrogenase (G6PD)


name: Measurement of glutathione reductase in red blood cells (RBCs)


name: Analysis of Helicobacter pylori urease activity in blood using C13 isotope


name: Analysis of urease activity in breath using C13 isotope for presence of Helicobacter pylori


name: Qualitative screening for heavy metal, any number of analytes


name: Quantitative measurement of heavy metal (not elsewhere specified), each metal measured


name: Hemoglobin analysis and measurement, electrophoresis


name: Fractionation and quantitation of hemoglobin using electrophoresis


name: Fractionation and measurement of hemoglobin using chromatography


name: Nonautomated measurement of hemoglobin using copper sulfate method


name: Qualitative analysis of fetal hemoglobin (Hb F)


name: Hemoglobin A1C level, by device for home use


name: Quantitative measurement of methemoglobin in hemoglobin


name: Quantitative measurement of sulfhemoglobin in hemoglobin


name: Measurement of b-hexosaminidase, each assay


name: Hydroxyproline (amino acid) measurement, free


name: Analysis of substance using immunoassay technique, multiple step method


name: Measurement of substance using immunoassay technique, by radioimmunoassay


name: Ketosteroids, 17 (hormone) measurement, total


name: Ketosteroids, 17 (hormone) measurement, fractionation


name: Measurement of human placental lactogen (HPL)


name: Lipoprotein level, electrophoretic separation and quantitation


name: Separation and quantitation of lipoprotein in blood using electrophoresis


name: High resolution fractionation and quantitation of lipoprotein with subclasses in blood


name: Lipoprotein level, quantitation of lipoprotein particle number(s)


name: Quantitation of lipoprotein particle numbers in blood


name: Quantitation of lipoprotein particle numbers with lipoprotein subclasses in blood


name: Qualitative mass spectrometry and tandem mass spectrometry, non-drug analyte (not elsewhere specified), each specimen


name: Quantitative mass spectrometry and tandem mass spectrometry, non-drug analyte (not elsewhere specified), each specimen


name: Analysis of myelin basic protein (MBP) in cerebrospinal fluid


name: Nephelometry, each analyte (not elsewhere specified)


name: Quantitative measurement of total organic acids, each specimen


name: Qualitative analysis of organic acids, each specimen


name: Quantitative measurement of single organic acid


name: Phosphatase (enzyme) level, alkaline, heat stable


name: Measurement of heat stable alkaline phosphatase (total not included)


name: Phosphatase (enzyme) measurement, alkaline, isoenzymes


name: Measurement of 6-phosphogluconate dehydrogenase in red blood cells (RBCs)


name: Qualitative evaluation of cervicovaginal fluid for placental alpha microglobulin-1 (PAMG-1), each specimen


name: Qualitative evaluation of cervicovaginal fluid for specific amniotic fluid protein, each specimen


name: Measurement of prostaglandin, each prostaglandin measured


name: PSA (prostate specific antigen) measurement, complexed


name: Measurement of total protein in plasma (except by refractometry)


name: Measurement of total protein in serum (except by refractometry)


name: Measurement of total protein in whole blood (except by refractometry)


name: Measurement of total protein in urine (except by refractometry)


name: Measurement of total protein (except by refractometry)


name: Measurement of total protein using refractometry, any source


name: Fractionation and quantitation of protein in serum using electrophoresis


name: Fractionation and quantitation of protein in concentrated body fluid (other than serum) using electrophoresis


name: Western blot protein immunoassay on blood with interpretation and report


name: Western blot protein immunoassay on body fluid (other than blood) with interpretation and report


name: Protein measurement, immunological probe for band identification


name: Western blot protein immunological probe for band identification in blood with interpretation and report, each


name: Western blot protein immunological probe for band identification in body fluid (other than blood) with interpretation and report, each


name: Quantitative measurement protoporphyrin in red blood cells (RBCs)


name: Screening for protoporphyrin in red blood cells (RBCs)


name: Assay for endocrine receptor (other than estrogen or progesterone)


name: Spectrophotometry (analyte not elsewhere specified)


name: Measurement of specific gravity (except urine)


name: Analysis of sugars using thin-layer chromatography (TLC)


name: Carbohydrate analysis, single qualitative


name: Single qualitative analysis of sugars, each specimen


name: Carbohydrate analysis, multiple qualitative


name: Multiple qualitative analysis of sugars, each specimen


name: Carbohydrate analysis, single quantitative


name: Single quantitative analysis of sugars, each specimen


name: Carbohydrate analysis, multiple quantitative


name: Multiple quantitative analysis of sugars, each specimen


name: Direct measurement of bioavailable testosterone


name: Thyroxine (thyroid chemical), requiring elution


name: Measurement of triiodothyronine (T3) uptake


name: Thyroid hormone, T3 measurement, reverse


name: Troponin (protein) analysis, qualitative


name: Urea nitrogen level to assess kidney function, quantitative


name: Quantitative measurement of blood urea nitrogen (BUN)


name: Urea nitrogen level to assess kidney function, urine


name: Urea nitrogen level to assess kidney function, clearance


name: Measurement of uric acid (other than blood)


name: Quantitative measurement of urobilinogen in feces


name: Measurement of vitamin (not otherwise specified)


name: Estimated leukocyte and platelet count by microscopic examination of blood smear with manual differential leukocyte (WBC) count


name: Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count


name: Automated complete blood cell count (CBC)


name: Manual blood cell count, each blood cell type


name: Manual platelet count, each blood cell type


name: Manual red blood cell (RBC) count, each blood cell type


name: Manual white blood cell (WBC) count, each blood cell type


name: Automated reticulocyte count with multiple cellular parameters, direct measurement


name: Automated reticulocyte count with single cellular parameter, direct measurement


name: Assay for clotting factor II (prothrombin)


name: Assay for clotting factor V (accelerated globulin [AcG])


name: Assay for clotting factor V (proaccelerin)


name: 1-stage assay for clotting factor VIII (antihemophilic globulin [AHG])


name: Assay for coagulation factor VIII (von Willebrand [VW]) using ristocetin cofactor


name: Assay for factor VIII antigen (von Willebrand [VW])


name: Assay for clotting factor VIII (von Willebrand [VW]) with multimetric analysis


name: Assay for clotting factor IX (Christmas factor)


name: Assay for clotting factor IX (plasma thromboplastin component [PTC])


name: Assay for high molecular weight kininogen (Fitzgerald factor assay)


name: Coagulation time measurement, Lee and White


name: Coagulation time measurement, other methods


name: Coagulation time test (other methods not specified elsewhere)


name: Semiquantitative analysis of fibrin degradation products (FDP) and fibrinogen split products (FSP) using agglutination slide method


name: Coagulation function measurement, paracoagulation


name: Analysis of fibrin degradation products (FDP) and fibrinogen split products (FSP) using paracoagulation method


name: Coagulation function measurement, quantitative


name: Measurement of fibrin degradation products (FDP) and fibrinogen split products (FSP)


name: Coagulation function measurement, qualitative or semiquantitative


name: Semiquantitative analysis of D-dimer fibrin degradation products


name: Coagulation function measurement, D-dimer; quantitative


name: Coagulation function measurement, ultrasensitive, qualitative or semiquantitative


name: Ultrasensitive semiquantitative analysis of D-dimer fibrin degradation products


name: Screening for coagulopathy with interpretation and written report


name: Screening for fibrinolysins with interpretation and written report


name: Coagulation/fibrinolysis assay on whole blood using pharmacologic additive, with interpretation and written report, per day


name: Analysis of functional activity of coagulation and fibrinolysis (not otherwise specified), each analyte


name: Measurement of plasminogen (excluding antigenic assay)


name: Evaluation of red blood cell defect (Heinz bodies), direct


name: Induced Heinz bodies stain using acetylphenylhydrazine


name: Fetal hemoglobin or red blood cells measurement for assessment of fetal-maternal circulation, differential lysis


name: Rosette test for fetal red blood cells (RBCs) for fetomaternal hemorrhage


name: Red blood cell (RBC) mechanical fragility test


name: Red blood cell fragility measurement, unincubated


name: Unincubated red blood cell (RBC) osmotic fragility test


name: Red blood cell fragility measurement, incubated


name: Incubated red blood cell (RBC) osmotic fragility test


name: In vitro platelet aggregation study, each agent


name: Prothrombin time test with substitution of plasma fractions, each test


name: Clotting factor X assessment test, undiluted


name: Red blood cell sedimentation rate, to detect inflammation, automated


name: Sickling of red blood cell (RBC) using reduction test


name: Thrombin time, fibrinogen screening test, plasma


name: Coagulation assessment blood test, plasma or whole blood


name: Partial thromboplastin time test (PTT) using plasma


name: Partial thromboplastin time test (PTT) using whole blood


name: Partial thromboplastin time test (PTT) with substitution of plasma fractions, each test


name: Measurement of antibody (IgG) to allergic substance, each allergen


name: Quantitative allergen-specific immunoglobulin G (IgG) test, each allergen


name: Semiquantitative allergen-specific immunoglobulin G (IgG) test, each allergen


name: Quantitative measurement of allergen-specific immunoglobulin E (IgE) using crude allergen extract, each allergen


name: Semiquantitative measurement of allergen-specific immunoglobulin E (IgE) using crude allergen extract, each allergen


name: Measurement of antibody (IgE) to allergic substance, multiallergen screen


name: Qualitative multiallergen screening for allergen-specific immunoglobulin E (IgE)


name: Measurement of antibody (IgE) to allergic substance, recombinant or purified component, each


name: Quantitative measurement of allergen-specific immunoglobulin E (IgE) using purified allergen component, each allergen


name: Quantitative measurement of allergen-specific immunoglobulin E (IgE) using recombinant allergen component, each allergen


name: Semiquantitative measurement of allergen-specific immunoglobulin E (IgE) using purified allergen component, each allergen


name: Semiquantitative measurement of allergen-specific immunoglobulin E (IgE) using recombinant allergen component, each allergen


name: Antibody identification test, platelet associated immunoglobulin assay


name: Measurement of antibody for assessment of autoimmune disorder, titer


name: Evaluation of blood cross match and evaluation of irregular antibody with interpretation and written report


name: Investigation of transfusion reaction, including suspicion of transmissible disease, with interpretation and written report


name: Measurement C-reactive protein for detection of infection or inflammation, high sensitivity


name: Measurement of high sensitivity C-reactive protein (hsCRP)


name: Assay for beta 2 Glycoprotein I antibody, each antibody


name: Assay for cardiolipin (phospholipid) antibody, each Ig class


name: Measurement of complement (immune system proteins), antigen,


name: Assay for complement antigen, each component


name: Assay for functional activity of complement antigen, each component


name: Measurement of complement fixation tests (immune system proteins)


name: Complement antigen fixation test, each antigen


name: Measurement of DNA antibody, native or double stranded


name: Assay for double stranded deoxyribonuclease acid (DNA) antibody


name: Assay for native deoxyribonuclease acid (DNA) antibody


name: Assay for single stranded deoxyribonuclease acid (DNA) antibody


name: Screening using fluorescent noninfectious agent antibody, each antibody


name: Immunologic analysis for detection of tumor antigen, quantitative; CA 15-3


name: Quantitative immunoassay for CA 15-3 (27.29) tumor antigen


name: Immunologic analysis for detection of tumor antigen, quantitative; CA 19-9


name: Immunologic analysis for detection of tumor antigen, quantitative; CA 125


name: Quantitative immunoassay for tumor antigen, each


name: Detection of infectious agent antibody, quantitative


name: Quantitative immunoassay for infectious agent antibody (not otherwise specified)


name: Semiquantitative immunoassay for infectious agent antibody using reagent strip


name: Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])


name: Test for detection of severe acute respiratory syndrome coronavirus 2 (Covid-19) antibody, qualitative or semiquantitative


name: Qualitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody using single-step method


name: Semiquantitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody using reagent strip


name: Semiquantitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody using single-step method


name: Immunoelectrophoresis of body fluid (other than serum) with concentration


name: Immunologic analysis technique, unspecified


name: Immunodiffusion (not elsewhere specified)


name: Qualitative gel diffusion, each antibody


name: Immunologic analysis technique on serum (immunofixation)


name: Immunologic analysis technique on body fluid, other fluids with concentration


name: Immunofixation electrophoresis of body fluid (other than serum) with concentration


name: White blood cell function measurement, mitogen or antigen induced blastogenesis


name: Lymphocyte transformation using antigen induced blastogenesis


name: Lymphocyte transformation using mitogen induced blastogenesis


name: Quantitative measurement of mononuclear cell antigen (not otherwise specified), each antigen


name: Analysis of microsomal antibody, each antibody


name: Screening for particle agglutination, each antibody


name: Particle agglutination titer, each antibody


name: Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); screen


name: Screening test for detection of severe acute respiratory syndrome coronavirus 2 (Covid-19) neutralizing antibody


name: Screen for neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)


name: Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); titer


name: Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (COVID-19)


name: Quantitative measurement of rheumatoid factor


name: Tuberculosis test, enumeration of T-cells


name: Unlisted antigen skin test, each antigen


name: Qualitative assay for syphilis-related nontreponemal antibody


name: Quantitative assay for syphilis-related nontreponemal antibody


name: Bacterium (not specified elsewhere) antibody assay


name: Chlamydia immunoglobulin M (IgM) antibody titer


name: Cytomegalovirus (CMV) immunoglobulin M (IgM) antibody titer


name: Analysis for antibody to Epstein-Barr virus (mononucleosis virus), early antigen


name: Analysis for antibody to Epstein-Barr virus (mononucleosis virus), nuclear antigen


name: Assay for fungus antibody (not elsewhere specified)


name: Assay for helminth antibody (not elsewhere specified)


name: Human T cell lymphotropic virus Type I (HTLV-I) antibody titer


name: Human T cell lymphotropic virus Type II virus (HTLV-II) antibody titer


name: Confirmatory test for Human T cell lymphotropic I virus (HTLV-I) antibody


name: Confirmatory test for Human T cell lymphotropic II virus (HTLV-II) antibody


name: Confirmatory test for human immunodeficiency virus (HIV) antibody


name: Assay for hepatitis delta (HepD) agent antibody


name: Nonspecific herpes simplex virus (HSV) antibody titer


name: Herpes simplex type 1 (HSV 1) antibody titer


name: Herpes simplex type 2 (HSV 2) antibody titer


name: Assay for human immunodeficiency virus type 1 (HIV-1) antibody


name: Assay for human immunodeficiency virus type 2 (HIV-2) antibody


name: Combined assay for human immunodeficiency virus type 1 and 2 (HIV-1, HIV-2) antibodies


name: Assay for hepatitis B core antibody (HBcAb) immunoglobulin M (IgM) core antibody


name: Assay for Hepatitis A antibody (HAAb) immunoglobulin M (IgM) antibody


name: Assay for John Cunningham (JC) virus antibody


name: John Cunningham (JC) virus antibody titer


name: Assay for protozoa antibody (not elsewhere specified)


name: Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])


name: Measure of severe acute respiratory syndrome coronavirus 2 (Covid-19) antibody


name: Measurement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody


name: Tetanus (Clostridium tetani) antibody titer


name: Toxoplasma immunoglobulin M (IgM) antibody titer


name: Assay for West Nile virus immunoglobulin M (IgM) antibody


name: Assay for virus antibody (not elsewhere specified)


name: Assay for Zika virus immunoglobulin M (IgM) antibody


name: Confirmatory hepatitis C (HepC) antibody titer


name: Immunologic analysis for autoimmune disease, with titration


name: Immunologic analysis for autoimmune disease, without titration


name: Transplant antibody measurement, quick method


name: Screening for cytotoxic percent reactive antibody (PRA) in serum using quick method


name: Immunologic analysis for autoimmune disease, A, B, or C, single antigen


name: Human leukocyte antigen (HLA) typing of antigen A, single antigen


name: Human leukocyte antigen (HLA) typing of antigen B, single antigen


name: Human leukocyte antigen (HLA) typing of antigen C, single antigen


name: Immunologic analysis for autoimmune disease, A, B, or C, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen A, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen B, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen C, multiple antigens


name: Immunologic analysis for autoimmune disease, DR/DQ, single antigen


name: Human leukocyte antigen (HLA) typing of antigen DQ, single antigen


name: Human leukocyte antigen (HLA) typing of antigen DR, single antigen


name: Immunologic analysis for autoimmune disease, DR/DQ, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen DQ, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen DR, multiple antigens


name: Immunologic analysis for autoimmune disease, lymphocyte culture, mixed


name: Mixed lymphocyte culture (MLC) for human leukocyte antigen (HLA) typing


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, first sample dilution


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, first serum sample


name: Immunologic analysis for organ transplant, each additional serum sample or sample dilution


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, each additional sample dilution


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, each additional serum sample


name: Qualitative assessment for antibody detection of human leukocyte antigens (HLA) Class I and II


name: Qualitative assessment for antibody detection of human leukocyte antigen (HLA) Class I


name: Qualitative assessment for antibody detection of human leukocyte antigen (HLA) Class II


name: Antibody detection for human leukocyte antigen (HLA) class I by qualitative panel using complete HLA phenotypes


name: Antibody detection for human leukocyte antigen (HLA) class II by qualitative panel using complete HLA phenotypes


name: Antibody detection with high definition qualitative panel for human leukocyte antigen (HLA) class I


name: Antibody detection for human leukocyte antigen (HLA) class I by semiquantitative panel


name: Antibody detection for human leukocyte antigen (HLA) class II by semiquantitative panel


name: Screening for red blood cell (RBC) antibody, each serum technique


name: Elution of red blood cell (RBC) antibody, each elution


name: Red blood cell (RBC) antibody panel, each panel for each serum technique


name: Red blood cell antibody detection test, indirect


name: Indirect qualitative antihuman globulin test (Coombs test), each reagent red cell


name: Indirect antihuman globulin test (Coombs test), each antibody titer


name: Processing and storage of blood unit or component, predeposited


name: Intraoperative salvage, collection processing, and storage of autologous blood


name: Intraoperative salvage, collection processing, and storage of autologous blood component


name: Postoperative salvage, collection processing, and storage of autologous blood


name: Postoperative salvage, collection processing, and storage of autologous blood component


name: Antigen testing of donor blood using reagent serum, each antigen test


name: Screening test for compatible blood unit, using patient serum


name: Antigen screening of donor blood for compatibility using patient serum, per unit screened


name: Red blood cell (RBC) antigen testing (other than ABO or Rh (D), each RBC antigen


name: Compatibility testing of blood for transfusion using immediate spin technique, each unit


name: Blood unit compatibility test, incubation technique


name: Compatibility testing of blood for transfusion using incubation spin technique, each unit


name: Blood unit compatibility test, antiglobulin technique


name: Compatibility testing of blood for transfusion using antiglobulin technique, each unit


name: Blood unit compatibility test, electronic


name: Electronic compatibility testing of blood for transfusion, each unit


name: Thawing of fresh frozen plasma, each unit


name: Preparation and freezing of blood, each unit


name: Preparation, freezing, and thawing of frozen blood, each unit


name: Screening of auto-hemolysins and auto-agglutinins, each screen


name: Volume reduction of blood product, each unit


name: Pretreatment of red blood cells for use in red blood cells antibody analysis and measurement, incubation with chemical agents or drugs


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by incubation, with each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells for use in red blood cells antibody analysis and measurement, by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification by density gradient separation


name: Pretreatment of serum for use in red blood cell antibody analysis and measurement, incubation with drugs


name: Pretreatment of serum by incubation with drug for use in red blood cell (RBC) antibody identification, each


name: Pretreatment of serum for use in red blood cell antibody analysis and measurement, by dilution


name: Pretreatment of serum by dilution for use in red blood cell (RBC) antibody identification


name: Pretreatment of serum for use in red blood cell antibody analysis and measurement, incubation with inhibitors


name: Pretreatment of serum by incubation with inhibitors for use in red blood cell (RBC) antibody identification, each


name: Pretreatment of serum for use in red blood cell antibody identification by differential red cell absorption using patient red blood cells (RBCs), each absorption


name: Pretreatment of serum for use in red blood cell antibody identification by differential red cell absorption using red blood cells (RBCs) of known phenotype, each absorption


name: Aerobic bacterial culture of stool with isolation and presumptive identification of isolate, each plate


name: Bacterial culture, any other source except urine, blood or stool, aerobic


name: Bacterial culture, any source except aerobic urine, aerobic blood and aerobic stool, with isolation and presumptive identification of isolate


name: Quantitative aerobic bacterial culture with isolation and presumptive identification of isolate, any source except urine, blood, or stool


name: Quantitative anaerobic bacterial culture with isolation and presumptive identification of isolate, any source except urine, blood, or stool


name: Bacterial culture, any source, except blood, anaerobic


name: Bacterial culture with isolation and presumptive identification of isolate, any source except anaerobic blood


name: Definitive identification of anaerobic isolate in bacterial culture using additional methods, each isolate


name: Definitive identification of aerobic isolate in bacterial culture using additional methods, each isolate


name: Presumptive culture for pathogenic organism, screening only


name: Presumptive culture for pathogenic organism, screening only, with colony estimation using density chart


name: Presumptive identification of isolate from fungal culture (except blood)


name: Definitive identification of yeast organism isolated from fungal culture


name: Definitive identification of mold isolated from fungal culture


name: Bacterial culture for Mycoplasma, any source


name: Bacterial culture for Chlamydia, any source


name: Bacterial culture for acid-fast bacilli with isolation and presumptive identification of isolate, any source


name: Procedure for definitive identification of Mycobacterium isolated from bacterial culture, each isolate


name: Identification of organisms by immunologic analysis, immunofluorescent method


name: Typing of culture using immunofluorescent method, each antiserum


name: Typing of culture using gas liquid chromatography (GLC) method


name: Typing of culture using high pressure liquid chromatography (HPLC) method


name: Typing of culture using immunologic method other than immunofluorescence, per antiserum


name: Typing of culture with identification by direct nucleic acid probe technique, per culture, each organism probed


name: Typing of culture with identification by direct nucleic acid probe technique, per isolate, each organism probed


name: Identification of organisms by genetic analysis, amplified probe technique


name: Typing of culture with identification by amplified nucleic acid probe technique, per culture, each organism probed


name: Typing of culture with identification by amplified nucleic acid probe technique, per isolate, each organism probed


name: Identification of organisms by nucleic acid sequencing method


name: Typing of culture with identification using nucleic acid sequencing method, each isolate


name: Typing of culture using method (not elsewhere specified)


name: Dark field microscopic examination for organism, includes specimen collection


name: Specimen collection and dark field examination, any source


name: Concentration and identification of direct smear for ova and parasites


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), agar dilution method


name: Antimicrobial agent susceptibility study using agar dilution method, per agent


name: Antimicrobial agent susceptibility study using disk method, per plate, 12 or fewer agents


name: Detection of antimicrobial drug (antibiotic, antifungal, antiviral)


name: Antimicrobial agent susceptibility study using enzyme detection, per enzyme


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution


name: Minimum inhibitory concentration (MIC) antimicrobial agent susceptibility study using agar dilution method, each antimicrobial, per plate


name: Minimum inhibitory concentration (MIC) antimicrobial agent susceptibility study using microdilution method, each antimicrobial, per plate


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution, each plate


name: Minimum lethal concentration (MLC) antimicrobial agent susceptibility study using agar dilution method, per plate


name: Minimum lethal concentration (MLC) antimicrobial agent susceptibility study using microdilution method, per plate


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), macrobroth dilution method


name: Antimicrobial agent susceptibility study using macrobroth dilution method, each agent


name: Antimicrobial agent susceptibility study on mycobacteria using proportion method, each agent


name: Special Gram or Giemsa stain for microorganism


name: Special fluorescent and/or acid fast stain for microorganism


name: Smear from primary source with fluorescent and acid fast stain for bacteria, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for cell type, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for fungus, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for parasite, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for virus with interpretation


name: Special stain for inclusion bodies or parasites


name: Wet mount smear from primary source for infectious agent, with interpretation


name: Tissue examination by potassium hydroxide (KOH) slide of sample from hair for ectoparasite ova


name: Tissue examination by potassium hydroxide (KOH) slide of sample from hair for fungus


name: Tissue examination by potassium hydroxide (KOH) slide of sample from hair for mite


name: Tissue examination by potassium hydroxide (KOH) slide of sample from nail for ectoparasite ova


name: Tissue examination by potassium hydroxide (KOH) slide of sample from nail for fungus


name: Tissue examination by potassium hydroxide (KOH) slide of sample from nail for mite


name: Tissue examination by potassium hydroxide (KOH) slide of sample from skin for ectoparasite ova


name: Tissue examination by potassium hydroxide (KOH) slide of sample from skin for fungus


name: Tissue examination by potassium hydroxide (KOH) slide of sample from skin for mite


name: Additional study of tissue culture viral isolate, each isolate


name: Definitive identification of tissue culture viral isolate, each isolate


name: Virus isolation using centrifuge enhanced technique and identification using immunofluorescence stain, each virus


name: Virus isolation and identification by nonimmunologic method


name: Adenovirus antigen detection by immunofluorescent technique


name: Bordetella parapertussis antigen detection by immunofluorescent technique


name: Bordetella pertussis antigen detection by immunofluorescent technique


name: Enterovirus antigen detection by direct fluorescent antibody (DFA) technique


name: Detection test by immunofluorescent technique for giardia (intestinal parasite)


name: Giardia antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for chlamydia


name: Chlamydia trachomatis antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for cytomegalovirus (CMV)


name: Cytomegalovirus antigen detection by direct fluorescent antibody (DFA) technique


name: Cryptosporidium antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for herpes simplex virus type 2


name: Herpes simplex virus type 2 antigen detection by immunofluorescent technique


name: Herpes simplex virus type 1 antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for influenza B virus


name: Influenza B virus antigen detection by immunofluorescent technique


name: Influenza A virus antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for legionella pneumophila (water borne bacteria)


name: Legionella pneumophila antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for parainfluenza virus


name: Parainfluenza virus antigen detection by immunofluorescent technique, each type


name: Respiratory syncytial virus antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for pneumocystis carinii (respiratory parasite)


name: Pneumocystis carinii antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for rubeola (measles virus)


name: Rubeola antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for treponema pallidum (syphilis organism)


name: Treponema pallidum antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for varicella (chicken pox) zoster virus


name: Varicella zoster virus antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for organism


name: Polyvalent infectious agent antigen detection using immunofluorescent technique, each organism


name: Detection test by immunofluorescent technique for multiple organisms


name: Detection test by immunoassay technique for adenovirus enteric types 40/41


name: Detection test by immunoassay technique for Aspergillus (fungus)


name: Detection test by immunoassay technique for Clostridium difficile toxins (stool pathogen)


name: Detection test by immunoassay technique for Cryptosporidium (parasite)


name: Detection test by immunoassay technique for cytomegalovirus


name: Detection test by immunoassay technique for Escherichia coli 0157 (E. coli)


name: Detection test by immunoassay technique for Entamoeba histolytica dispar group (parasite)


name: Detection test by immunoassay technique for Entamoeba histolytica group (parasite)


name: Detection test by immunoassay technique for Helicobacter pylori (GI tract bacteria)


name: Detection test by immunoassay technique for hepatitis B surface antigen neutralization


name: Detection test by immunoassay technique for hepatitis Be surface antigen


name: Detection test by immunoassay technique for hepatitis D


name: Detection test by immunoassay technique for Histoplasma capsulatum (parasite)


name: Detection test by immunoassay technique for respiratory syncytial virus (RSV)


name: Detection test by immunoassay technique for rotavirus


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])


name: Qualitative enzyme immunoassay (EIA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Qualitative enzyme-linked immunosorbent assay (ELISA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Qualitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen using multiple-step method


name: Qualitative immunochemiluminometric assay (IMCA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Semiquantitative enzyme immunoassay (EIA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Semiquantitative enzyme-linked immunosorbent assay (ELISA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Semiquantitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen using multiple-step method


name: Semiquantitative immunochemiluminometric assay (IMCA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Detection test by immunoassay technique for Streptococcus, group A (strep)


name: Infectious agent antigen detection using qualitative multiple step immunoassay technique (not otherwise specified), each organism


name: Unspecified infectious agent antigen detection using semiquantitative multiple step immunoassay technique (not otherwise specified), each organism


name: Polyvalent infectious agent antigen detection by qualitative multiple step immunoassay technique, each polyvalent antiserum


name: Polyvalent infectious agent antigen detection by semiquantitative multiple step immunoassay technique, each polyvalent antiserum


name: Detection by nucleic acid Bartonella henselae and Bartonella quintana (bacteria), amplified probe technique


name: Bartonella henselae detection by amplified nucleic acid probe technique


name: Bartonella quintana detection by amplified nucleic acid probe technique


name: Detection by nucleic acid Bartonella henselae and Bartonella quintana (bacteria), quantification


name: Bartonella henselae quantification by nucleic acid probe technique


name: Bartonella quintana quantification by nucleic acid probe technique


name: Detection by nucleic acid for borrelia burgdorferi (bacteria), direct probe technique


name: Borrelia burgdorferi detection by direct nucleic acid probe technique


name: Detection by nucleic acid for borrelia burgdorferi (bacteria), amplified probe technique


name: Borrelia burgdorferi detection by amplified nucleic acid probe technique


name: Candida detection by direct nucleic acid probe technique


name: Detection test for candida species (yeast), amplified probe technique


name: Candida detection by amplified nucleic acid probe technique


name: Detection test for candida species (yeast), quantification


name: Candida quantification by nucleic acid probe technique


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique and multiplex reverse transcription, multiple subtypes, 12-25 targets


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique and multiplex reverse transcription, multiple types, 12-25 targets


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique, multiple subtypes, 12-25 targets


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique, multiple types, 12-25 targets


name: Detection test by nucleic acid for chlamydia pneumoniae, direct probe technique


name: Chlamydia pneumoniae detection by direct nucleic acid probe technique


name: Chlamydia pneumoniae detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for chlamydia pneumoniae, quantification


name: Chlamydia pneumoniae quantification by nucleic acid probe technique


name: Detection test by nucleic acid for chlamydia, direct probe technique


name: Chlamydia trachomatis detection by direct nucleic acid probe technique


name: Chlamydia trachomatis detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for chlamydia trachomatis, quantification


name: Chlamydia trachomatis quantification by nucleic acid probe technique


name: Detection test by nucleic acid for clostridium difficile, amplified probe technique


name: Clostridium difficile toxin gene detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for cytomegalovirus (CMV), direct probe technique


name: Cytomegalovirus detection by direct nucleic acid probe technique


name: Cytomegalovirus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for cytomegalovirus, quantification


name: Cytomegalovirus quantification by nucleic acid probe technique


name: Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique


name: Enterovirus detection by amplified nucleic acid probe technique


name: Enterovirus detection by amplified nucleic acid probe technique with reverse transcription


name: Detection test by nucleic acid for Vancomycin resistance strep (VRE), amplified probe technique


name: Vancomycin resistant bacteria detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for influenza virus, each type or subtype


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each subtype


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each type


name: Detection test by nucleic acid for multiple types influenza virus


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, first 2 subtypes


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, first 2 types


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each additional influenza virus type


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each additional sub-type beyond 2


name: Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 3-5 targets


name: Gastrointestinal pathogen detection by nucleic acid using multiplex reverse transcription and multiplex amplified probe technique, 3-5 targets


name: Gastrointestinal pathogen detection by nucleic acid using multiplex reverse transcription and multiplex amplified probe technique, 6-11 targets


name: Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique and multiplex reverse transcription, multiple subtypes, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique and multiplex reverse transcription, multiple types, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique, multiple subtypes, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique, multiple types, 12-25 targets


name: Detection test for gardnerella vaginalis (bacteria), direct probe technique


name: Gardnerella vaginalis detection by direct nucleic acid probe technique


name: Gardnerella vaginalis detection by amplified nucleic acid probe technique


name: Detection test for gardnerella vaginalis (bacteria), quantification


name: Gardnerella vaginalis quantification by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis B virus, amplified probe technique


name: Hepatitis B (HepB) virus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis B virus, quantification


name: Hepatitis B (HepB) virus quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis C virus, direct probe technique


name: Hepatitis C (HepC) virus detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis C virus, amplified probe technique


name: Hepatitis C (HepC) virus detection by amplified nucleic acid probe technique


name: Hepatitis C (HepC) virus detection by amplified nucleic acid probe technique with reverse transcription


name: Hepatitis C (HepC) virus quantification by nucleic acid probe technique


name: Hepatitis C (HepC) virus quantification by nucleic acid probe technique with reverse transcription


name: Hepatitis G virus detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis G virus, amplified probe technique


name: Hepatitis G virus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis G virus, quantification


name: Hepatitis G virus quantification by nucleic acid probe technique


name: Detection test by nucleic acid for herpes simplex virus, direct probe technique


name: Herpes simplex virus detection by direct nucleic acid probe technique


name: Herpes simplex virus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for herpes simplex virus, quantification


name: Herpes simplex virus quantification by nucleic acid probe technique


name: Herpes virus-6 detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for herpes virus-6, amplified probe technique


name: Herpes virus-6 detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for herpes virus-6, quantification


name: Herpes virus-6 quantification by nucleic acid probe technique


name: Human immunodeficiency virus type 1 (HIV-1) detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for HIV-1 virus, amplified probe technique


name: Human immunodeficiency virus type 1 (HIV-1) detection by amplified nucleic acid probe technique


name: Human immunodeficiency virus type 1 (HIV-1) detection by amplified nucleic acid probe technique with reverse transcription


name: Detection test by nucleic acid for HIV-1 virus, quantification


name: Human immunodeficiency virus type 1 (HIV-1) quantification by nucleic acid probe technique


name: Human immunodeficiency virus type 1 (HIV-1) quantification by nucleic acid probe technique with reverse transcription


name: Detection test by nucleic acid for HIV-2 virus, direct probe technique


name: Human immunodeficiency virus type 2 (HIV-2) detection by direct nucleic acid probe technique


name: Human immunodeficiency virus type 2 (HIV-2) detection by amplified nucleic acid probe technique


name: Human immunodeficiency virus type 2 (HIV-2) detection by amplified nucleic acid probe technique and reverse transcription


name: Detection test by nucleic acid for HIV-2 virus, quantification


name: Human immunodeficiency virus type 2 (HIV-2) quantification by nucleic acid probe technique


name: Human immunodeficiency virus type 2 (HIV-2) quantification by nucleic acid probe technique and reverse transcription


name: Detection test by nucleic acid for legionella pneumophila (water borne bacteria), direct probe technique


name: Legionella pneumophila detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique


name: Legionella pneumophila detection by amplified nucleic acid probe technique


name: Legionella pneumophila quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria species (bacteria), direct probe technique


name: Mycobacteria species detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria species (bacteria), amplified probe technique


name: Mycobacteria species detection by amplified nucleic acid probe technique


name: Mycobacteria species quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria tuberculosis (TB bacteria), direct probe technique


name: Mycobacteria tuberculosis detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria tuberculosis (TB bacteria), amplified probe technique


name: Mycobacteria tuberculosis detection by amplified nucleic acid probe technique


name: Mycobacteria tuberculosis quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria avium-intracellulare (bacteria), direct probe technique


name: Mycobacteria avium-intracellulare detection by direct nucleic acid probe technique


name: Mycobacteria avium-intracellulare detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria avium-intracellulare (bacteria), quantification


name: Mycobacteria avium-intracellulare quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycoplasma pneumoniae (bacteria), direct probe technique


name: Mycoplasma pneumoniae detection by direct nucleic acid probe technique


name: Mycoplasma pneumoniae detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Mycoplasma pneumoniae (bacteria), quantification


name: Mycoplasma pneumoniae quantification by nucleic acid probe technique


name: Neisseria gonorrhoeae detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique


name: Detection of Neisseria gonorrhoeae nucleic acid by amplified probe technique


name: Detection test by nucleic acid for Neisseria gonorrhoeae (gonorrhoeae bacteria), quantification


name: Neisseria gonorrhoeae quantification by nucleic acid probe technique


name: Detection test by nucleic acid for human papillomavirus (hpv), low-risk types


name: Human Papillomavirus (HPV) detection by nucleic acid for low-risk types


name: Detection test by nucleic acid for human papillomavirus (hpv), high-risk types


name: Human Papillomavirus (HPV) detection by nucleic acid for high-risk types


name: Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only


name: Human Papillomavirus (HPV) type 16 and 18 detection by nucleic acid probe technique


name: Human Papillomavirus (HPV) type 16, 18, and 45 detection by nucleic acid probe technique


name: Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets


name: Respiratory virus detection by nucleic acid using amplified probe technique, 3-5 targets


name: Respiratory virus detection by nucleic acid using multiplex reverse transcription technique, 3-5 targets


name: Respiratory virus detection by nucleic acid using amplified probe technique, 6-11 targets


name: Respiratory virus detection by nucleic acid using multiplex reverse transcription technique, 6-11 targets


name: Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 12-25 targets